2023-11-03 2024-12-31 false Capium Accounts Production 1.1 15257921 2023-11-03 2024-12-31 15257921 bus:AbridgedAccounts 2023-11-03 2024-12-31 15257921 bus:FRS102 2023-11-03 2024-12-31 15257921 bus:AuditExemptWithAccountantsReport 2023-11-03 2024-12-31 15257921 bus:SmallCompaniesRegimeForAccounts 2023-11-03 2024-12-31 15257921 bus:PrivateLimitedCompanyLtd 2023-11-03 2024-12-31 15257921 2023-11-03 2024-12-31 15257921 2024-12-31 15257921 bus:RegisteredOffice 2023-11-03 2024-12-31 15257921 core:WithinOneYear 2024-12-31 15257921 core:AfterOneYear 2024-12-31 15257921 1 2023-11-03 2024-12-31 15257921 bus:Director1 2023-11-03 2024-12-31 15257921 bus:Director1 2024-12-31 15257921 bus:Director2 2023-11-03 2024-12-31 15257921 bus:Director2 2024-12-31 15257921 bus:Director3 2023-11-03 2024-12-31 15257921 bus:Director3 2024-12-31 15257921 bus:Director4 2023-11-03 2024-12-31 15257921 bus:Director4 2024-12-31 15257921 2022-11-03 15257921 bus:LeadAgentIfApplicable 2023-11-03 2024-12-31 15257921 2023-11-02 15257921 bus:OrdinaryShareClass1 2023-11-03 2024-12-31 15257921 bus:OrdinaryShareClass1 2024-12-31 15257921 core:PlantMachinery 2023-11-03 2024-12-31 15257921 core:PlantMachinery 2024-12-31 15257921 core:PlantMachinery 2023-11-02 15257921 core:MotorCars 2023-11-03 2024-12-31 15257921 core:MotorCars 2024-12-31 15257921 core:MotorCars 2023-11-02 15257921 core:FurnitureFittings 2023-11-03 2024-12-31 15257921 core:FurnitureFittings 2024-12-31 15257921 core:FurnitureFittings 2023-11-02 15257921 core:ComputerEquipment 2023-11-03 2024-12-31 15257921 core:ComputerEquipment 2024-12-31 15257921 core:ComputerEquipment 2023-11-02 15257921 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-12-31 15257921 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-11-02 15257921 core:CostValuation core:Non-currentFinancialInstruments 2024-12-31 15257921 core:CostValuation core:Non-currentFinancialInstruments 2023-11-02 15257921 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-12-31 15257921 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-12-31 15257921 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-12-31 15257921 core:Non-currentFinancialInstruments 2024-12-31 15257921 core:Non-currentFinancialInstruments 2023-11-02 15257921 core:ShareCapital 2024-12-31 15257921 core:RetainedEarningsAccumulatedLosses 2024-12-31 15257921 dpl:Item1 2023-11-03 15257921 dpl:Item1 2024-12-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 15257921
England and Wales

 

 

 

MEDICANA INTERNATIONAL LIMITED



Abridged Accounts
 


Period of accounts

Start date: 03 November 2023

End date: 31 December 2024
 
 
Notes
 
2024
£
Fixed assets    
Tangible fixed assets 5 5,429,018 
5,429,018 
Current assets    
Debtors 1,408,399 
Cash at bank and in hand 100,922 
1,509,321 
Creditors: amount falling due within one year (627,086)
Net current assets 882,235 
 
Total assets less current liabilities 6,311,253 
Creditors: amount falling due after more than one year (2,819,115)
Provisions for liabilities 680,616 
Net assets 4,172,754 
 

Capital and reserves
   
Called up share capital 6 5,450,001 
Profit and loss account (1,277,247)
Shareholders' funds 4,172,754 
 


For the period ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476.
  2. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the board of directors on 25 June 2025 and were signed on its behalf by:


-------------------------------
CAN EMRE OZDEMIR
Director
1
General Information
MEDICANA INTERNATIONAL LIMITED is a private company, limited by shares, registered in England and Wales, registration number 15257921, registration address 3rd Floor 1 Ashley Road, Altrincham, Cheshire, United Kingdom, WA14 2DT.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Going concern basis
The directors believe that the company is experiencing good levels of sales growth and profitability, and that it is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Deferred taxation
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the reporting date.
Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis. Depreciation for purchased business assets are calculated according to the term of the lease:
Plant and machinery etc 23
Provisions
Provisions are recognised when the company has a present obligation as a result of a past event which it is more probable than not will result in an outflow of economic benefits that can be reasonably estimated.
2.

Directors' Emoluments

2024
£
Administrative Expenses
Directors Salaries 38,359 
Directors Pension Contributions 1,151 
39,510 
Number of directors to whom retirement benefits accrued Number
Defined contribution plans 1 
Defined benefit plans 1 

3.

Staff Costs

2024
£
Wages and salaries 78,984 
Social security costs 9,620 
Pension costs, defined contribution plan 2,232 
90,836 
Average number of employees during the period Number
Administration 1 

4.

Average number of employees

Average number of employees during the period was 1.
5.

Tangible fixed assets

Cost or valuation Plant and machinery etc   Total
  £   £
At 03 November 2023  
Additions 5,627,869    5,627,869 
Disposals  
At 31 December 2024 5,627,869    5,627,869 
Depreciation
At 03 November 2023  
Charge for period 198,851    198,851 
On disposals  
At 31 December 2024 198,851    198,851 
Net book values
Closing balance as at 31 December 2024 5,429,018    5,429,018 
Opening balance as at 03 November 2023  


6.

Share Capital

Authorised
5,450,001 Class A shares of £1.00 each
Allotted, called up and fully paid
2024
£
5,450,001 Class A shares of £1.00 each 5,450,001 
5,450,001 

2